Journal editorial - The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial
ESC Cardio Talk
00:00
Trial scope and Myval sizing advantage
Marie-Annick summarizes LANDMARK randomization and explains Myval's unique intermediate sizing advantage.
Play episode from 00:29
Transcript
